Products - Diabetes | Topic | NICE

Showing 7 products

Date | Sort by Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema in phakic eyes after an inadequate response to previous therapy (TA613)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
20 November 2019
Dapagliflozin with insulin for treating type 1 diabetes (TA597)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
28 August 2019
Sotagliflozin, in combination with insulin, for treating type 1 diabetes [ID1376]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
8 January 2020
Ticagrelor for preventing cardiovascular events in people with type 2 diabetes and coronary artery disease [ID1514]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Semaglutide for treating type 2 diabetes (ID1450)
Status:
Proposed
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Ranibizumab for treating diabetic retinopathy [ID1592]
Status:
Proposed
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]
Status:
Proposed
Programme:
Technology appraisal guidance
Expected publication date:
TBC